Problem

Oto addresses the persistent distress caused by tinnitus—the perception of ringing or other noise in the ears. The condition is widespread: Oto says 15% of adults experience it every day, while an independent global review estimates that 14% of adults experience tinnitus and 2% experience a severe form. The pain is not only the sound itself; it can undermine sleep, concentration, relaxation, and quality of life, while many sufferers are simply told there is no cure and that they must learn to live with it. Tinnitus also carries meaningful economic burden: U.S. healthcare costs have been estimated at $660 per patient per year, alongside broader costs to healthcare systems and society.

The main use case is therefore someone who needs practical, recurring help coping with tinnitus between clinical appointments—especially when it interferes with sleep, focus, or the ability to feel calm. Oto’s economic proposition is to make evidence-based support more accessible and less expensive than relying entirely on in-person treatment, although the available evidence does not establish a specific savings figure or overall revenue model.

Product / Service

Oto combines access to a tinnitus-specialist audiologist with a daily mobile app. Users are matched with a specialist, create a personalized plan, and use the app for roughly ten minutes a day between appointments. The app provides guided cognitive-behavioral exercises, relaxation and mindfulness sessions, breathing techniques, sleep-oriented routines, and a library of soothing soundscapes; users can track progress and share it with their provider, who can adjust the plan.

The service is designed to help users build behavioral coping skills and regain control over daily activities rather than promise a cure. Oto’s materials say its approach is grounded in methods recommended by NICE, Cochrane, and the American Academy of Otolaryngology. Its terms characterize the app as self-guided audio, education, and wellbeing content—not a substitute for medical care—and state that it is not FDA-approved; locked content is offered through a subscription whose price varies by currency and checkout conditions. A 2025 feasibility study described the app as a multimodal program combining education, CBT, relaxation, mindfulness, and sound therapy, and reported that users generally found it easy to use.

Market

Oto competes in digital health and app-delivered tinnitus self-management, occupying a hybrid position between a consumer subscription app and clinician-supported care. Alternatives include MindEar, which combines sound therapy, CBT, and other techniques, as well as sound-focused apps such as ReSound Relief, Starkey Relax, and Phonak Balance. More clinically intensive or differently delivered alternatives include specialist audiology care and Lenire’s bimodal neuromodulation approach. Oto’s differentiation is the combination of structured behavioral content, soundscapes, and optional specialist involvement rather than sound masking alone.

The product is commercially launched rather than pre-launch: Oto reports more than 200,000 program enrollments, a 4.7 App Store rating, and more than 1,000 five-star reviews, and its terms provide for paid subscriptions. Clinical validation is still developing rather than settled; Oto says its 198-participant DEFINE randomized trial, led by the University of Cambridge and co-funded by Innovate UK, is comparing Oto with one-to-one therapist-delivered CBT, with results still in peer review. The evidence gathered here does not verify revenue, profitability, or a current funding total, so traction is best characterized as substantial reported usage and early clinical validation rather than proven financial scale.